By Judge Pauses Rescheduling Hearing
DEA Chief Administrative Law Judge Derek C. Julius paused the federal cannabis rescheduling hearing this week to consider adding a new Government Accountability Office (GAO) report to the hearing.
The cannabis rescheduling hearing officially ended in July, and post-hearing briefs were filed in August. Until this week, the last step anticipated in the hearing process was the judge’s final ruling.
The National Drug & Alcohol Screening Association and the advocacy group DUID Victim Voices submitted the motion to include the GAO report on September 28. Officials and other interested parties have until October 13 to respond.
Cannabis stock prices sank this week after reports that the rescheduling hearing was delayed.
What the GAO Report Found
The report found that the DEA and FDA both lack procedures for properly evaluating and scheduling substances, and recommended that the agencies adopt policies to remedy the situation.
According to an excerpt from the GAO report, “DEA and FDA have policies that address aspects of the scheduling process, including a memorandum of understanding (MOU) for sharing information; however, these policies have gaps. For example, DEA does not have policies that identify roles, responsibilities, and procedures related to scheduling. FDA does not have policies or procedures specifying how its staff are to conduct evaluations or develop recommendations.
What Happens Next
Interested parties have until October 13 to respond to the motion. Judge Julius will weigh whether the GAO report should be added to the hearing.
The hearing itself concluded in July, with post-hearing briefs filed in August.
The federal cannabis rescheduling proceeding remains pending before Judge Julius.
